CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
2 research outputs found
Comparative evaluation of efficacy, pharmacodynamics, and safety of Hetero’s adalimumab (Mabura®, Hetero Biopharma Ltd.) and reference adalimumab (Humira®, Abbvie Inc.) in patients with active rheumatoid arthritis on concomitant methotrexate therapy
Author
A Jamshidi
AM Wasserman
+26 more
BR Meher
CS Crowson
D Aletaha
DT Felson
EC Keystone
FC Breedveld
Felson
G Castañeda-Hernández
GM Bartelds
GM Bartelds
GR Burmester
GR Burmester
J Crespi-Lofton
JA Singh
JM Hazes
JS Smolen
K Laiho
LM Mota
ME Weinblatt
O Sangha
P Apsangikar
R Fleischmann
RH Jani
RM Fleischmann
SB Cohen
TK Kvien
Publication venue
'Springer Science and Business Media LLC'
Publication date
Field of study
No full text
Crossref
Trypsinogen and chymotrypsinogen: potent anti-tumor agents
Author
Altrogge LM
Apsangikar P
+51 more
Awla D
Beuth J
Biziulevic GA
Brodrick JW
Burch ML
Chandanwale A
Dayati P
De Almeida VH
Gao X
Gewert K
Guy O
Halfon S
Hao F
Hattori T
He S
Hernández-Camarero P
Huang EH
Human Mesotrypsin S-TM
Kardos J
Katona G
Kawabata A
Kondreddy V
Kukor Z
Latha B
Ma G
Mcdonald C
Mitsuru E
Novak JF
Oppenheimer HL
Perán M
Perán M
Petru E
Popiela T
Rothman S
Ryu K
Sakalová A
Salameh MA
Shah D
Shoelson SE
Son Y-J
Szabó A
Szmola R
Takahashi M
Tamura S
Ungefroren H
Vajda T
Wald M
Wald M
Wald M
Yang Y
Zhou J
Publication venue
'Informa UK Limited'
Publication date
Field of study
No full text
Crossref